Ligand Pharmaceuticals | Passività Correnti



Current Liabilities Cambiamento Data
Amgen USD 20.48B 2.53B 2025-06
Arrowhead Research USD 194.53M 26.01M 2025-06
Baxter International USD 3.48B 3.03B 2025-03
Bristol-Myers Squibb USD 27.53B 3.46B 2025-06
Eli Lilly USD 39.02B 8.95B 2025-06
Gilead Sciences USD 11.19B 1.15B 2025-06
GlaxoSmithKline GBP 20.38B 453M 2025-06
Glaxosmithkline GBP 21.7B 238M 2024-12
Insmed USD 311.68M 72.45M 2025-06
Ionis Pharmaceuticals USD 897.24M 646.94M 2025-06
Ligand Pharmaceuticals USD 64.73M 6.05M 2025-06
MacroGenics USD 55.53M 3.78M 2024-12
Merck USD 26.04B 863M 2025-06
Pacira USD 313.16M 1.57M 2025-06
Pfizer USD 37.73B 1.27B 2025-06
Veracyte USD 76.43M 1.31M 2025-06


Ligand Pharmaceuticals Passività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.